MedTrace Logo

Investigation of the Optimal Calcium Supplement Following Roux-en-Y Gastric Bypass

NCT02830789 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2017-06-26

No results posted yet for this study

Summary

This study investigates whether calcium citrate or calcium carbonate are the optimal supplement to treat secondary hyperparathyroidism following Roux-en-Y gastric bypass operation.

Half of the participants will be randomized to receive calcium citrate, while the other half will receive calcium carbonate. The study will be double blinded.

Conditions

  • Roux-en-Y Gastric Bypass
  • Hyperparathyroidism, Secondary

Interventions

DIETARY_SUPPLEMENT

Calcium Carbonate

DIETARY_SUPPLEMENT

Calcium Citrate

DIETARY_SUPPLEMENT

Placebo

Tablet manufactured to mimic a calcium carbonate tablet

PROCEDURE

Roux-en-Y gastric bypass

Roux-en-Y gastric bypass surgery at least 12 months before study inclusion

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02830789 on ClinicalTrials.gov